Ganoderma Immunomodulatory Protein Gel for Chronic Wound Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chronic wounds and ulcers, particularly those associated with diabetes, pose a significant challenge due to slow healing rates and increased risk of infection, with existing treatments not fully addressing the complexity of these conditions.
Innovation Solution
A composition comprising a gel-forming agent and Ganoderma immunomodulatory protein, with specific amino acid sequences, is topically applied to enhance wound healing by promoting a conducive environment for tissue repair and infection control.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional wound healing treatments are used, then basic wound care is provided, but chronic wounds and ulcers heal slowly and fail to improve significantly
Solution Approach 1:
The patent combines immunomodulatory proteins (such as cytokines, growth factors) with gel-forming agents to create a composite topical composition. This composite material delivers multiple therapeutic functions simultaneously: the gel matrix provides wound bed coverage and controlled release, while the immunomodulatory proteins actively stimulate healing processes, thereby accelerating chronic wound healing beyond conventional treatments.
Solution Approach 2:
The patent utilizes immunomodulatory proteins to change the biochemical parameters of the wound environment. These proteins modify local immune responses, growth factor concentrations, and cellular activity levels, transforming the wound bed from a chronic non-healing state to an active healing state, thus significantly improving healing rates.
2Adaptability or versatility
If extensive drugs or compositions are developed for wound healing, then treatment options increase, but the complexity of treating chronic wounds remains unresolved
Solution Approach 1:
The patent creates a multi-functional topical composition that addresses multiple aspects of chronic wound healing simultaneously. The gel-forming agent provides wound protection and moisture management, while immunomodulatory proteins regulate immune responses and stimulate tissue regeneration. This single composition performs multiple therapeutic functions that would otherwise require separate treatments, simplifying the overall treatment approach.
3Reliability
If topical compositions are applied to chronic wounds, then wound bed coverage is provided, but infection control and tissue repair promotion remain insufficient
Solution Approach 1:
The patent employs immunomodulatory proteins as biological mediators that interact with the wound environment to control infection and promote healing. These proteins modulate immune cell activity, enhance phagocytic function, and regulate inflammatory responses, thereby providing reliable infection control while simultaneously stimulating tissue repair processes.
Data Source
AI summary
The present disclosure provides compositions comprising Ganoderma immunomodulatory protein or a recombinant thereof and a gel-forming agent. Also provided are methods for the treatment of chronic wounds, ulcers or sores, and methods using the compositions.